ReviewInternational journal of molecular sciences2025

Angiotensin-Converting Enzyme Inhibitors to Prevent Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Scientific Speculation or an Opportunity to Improve Real Clinical Practice?

Aurelio Seidita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.